Aegerion Pharmaceuticals (AEGR) Names Craig E. Fraser as President, U.S.
Tweet
Share
E-mailGet Alerts AEGR Hot Sheet
Join SI Premium – FREE
Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR) announced the appointment of Craig E. Fraser as President, U.S.
Mr. Fraser was most recently Vice President, Global Disease Areas at Pfizer Inc. (NYSE: PFE) responsible for the commercial development and global marketing for the Specialty Cardiovascular, Anti-Bacterial, Anti-Fungal, Gastrointestinal and Anti-Viral disease areas, where he managed a portfolio of six products totaling over three billion dollars in revenue and multiple new products in development.
Mr. Fraser was most recently Vice President, Global Disease Areas at Pfizer Inc. (NYSE: PFE) responsible for the commercial development and global marketing for the Specialty Cardiovascular, Anti-Bacterial, Anti-Fungal, Gastrointestinal and Anti-Viral disease areas, where he managed a portfolio of six products totaling over three billion dollars in revenue and multiple new products in development.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- J.M. Smucker names Jeff Varcoe as SVP of Science and Technical
- Jack in the Box names former Taco Bell executive as president
- Duos Technologies names Dipan Patel as chief operating officer
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
